FOXO TECHNOLOGIES INC. Distributed Earnings
FOXO TECHNOLOGIES INC. (FOXO) reported Distributed Earnings of $11.29 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Notes
us-gaap:DistributedEarnings · last filed 2023-08-10
- FOXO TECHNOLOGIES INC. distributed earnings for the quarter ending 2023-06-30 was $11.29M, a 52.02% decline year-over-year.
- FOXO TECHNOLOGIES INC. distributed earnings for the quarter ending 2023-03-31 was $7.64M, a 38.23% decline year-over-year.
- FOXO TECHNOLOGIES INC. distributed earnings for the quarter ending 2022-12-31 was $18.32M, a 1996.45% increase year-over-year.
- FOXO TECHNOLOGIES INC. distributed earnings for the quarter ending 2022-09-30 was $41.03M, a 50.60% increase year-over-year.
- FOXO TECHNOLOGIES INC. distributed earnings for fiscal 2022 was $95.25M, a 147.49% increase from fiscal 2021.
- FOXO TECHNOLOGIES INC. distributed earnings for fiscal 2021 was $38.49M.
| Period end | Distributed Earnings 3 month | Distributed Earnings 6 month | Distributed Earnings 9 month | Distributed Earnings 12 month |
|---|---|---|---|---|
| 2023-06-30 | $11.29M 10-Q · filed 2023-08-10 | $18.93M 10-Q · filed 2023-08-10 | $37.26M derived: sum of 3 quarters · filed 2023-08-10 | $78.28M derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | $7.64M 10-Q · filed 2023-05-11 | $25.96M derived: sum of 2 quarters · filed 2023-05-11 | $66.99M derived: sum of 3 quarters · filed 2023-05-11 | $90.53M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-12-31 | $18.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $59.35M derived: sum of 2 quarters · filed 2023-03-31 | $82.89M derived: sum of 3 quarters · filed 2023-08-10 | $95.25M 10-K · filed 2023-03-31 |
| 2022-09-30 | $41.03M 10-Q · filed 2022-11-21 | $64.56M derived: sum of 2 quarters · filed 2023-08-10 | $76.93M 10-Q · filed 2022-11-21 | $77.81M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-06-30 | $23.54M 10-Q · filed 2023-08-10 | $35.91M 10-Q · filed 2023-08-10 | $36.78M derived: sum of 3 quarters · filed 2023-08-10 | $64.02M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $12.37M 10-Q · filed 2023-05-11 | $13.24M derived: sum of 2 quarters · filed 2023-05-11 | $40.48M derived: sum of 3 quarters · filed 2023-05-11 | |
| 2021-12-31 | $874.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $28.11M derived: sum of 2 quarters · filed 2023-03-31 | $38.49M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $27.24M 10-Q · filed 2022-11-21 | $37.61M 10-Q · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |